tirzepatide nhs Lilly obesity drug Mounjaro to be offered in Britain's after watchdog nod 📣 Mounjaro (Tirzepatide) – Important

By 48 weeks, the weight loss increased to 24.2% of their body, or 57.8 pounds

Research Use Only : This product is sold strictly for research purposes and is not intended for human consumption, therapeutic use, or veterinary applications

Clinical Evidence: Stronger Than Most, But Inconsistent A 2015 meta-analysis by Gauthier et al

Learn more: To view or add a comment, sign in Weight-loss drug reduces heart risks The weight-loss drug semaglutide, found in Wegovy and Ozempic, cuts the risk of cardiovascular problems such as heart attack or stroke, regardless of how much weight people lose, according to a new study published in the Lancet